AbsEn.i
Analysis
an2020
Racine
Analysis
an2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars) - Analysis (an2020)

Index « AbsEn.i » - entrée « efficacy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
efficacious < efficacy < efficiency  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000048 (2020) H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine][Potential antiviral therapeutics for 2019 Novel Coronavirus].
000057 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000074 (2020) [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)].
000307 (2020) Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France]Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?
000360 (2020) Rong Chen [République populaire de Chine] ; Yuan Zhang [République populaire de Chine] ; Lei Huang [République populaire de Chine] ; Bi-Heng Cheng [République populaire de Chine] ; Zhong-Yuan Xia [République populaire de Chine] ; Qing-Tao Meng [République populaire de Chine]Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients
000383 (2020) Péter Boldog ; Tamás Tekeli ; Zsolt Vizi ; Attila Dénes ; Ferenc A. Bartha ; Gergely RöstRisk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
000490 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000615 (2020) Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis]Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
000648 (2020) Tony Y. Hu [États-Unis] ; Matthew Frieman [États-Unis] ; Joy Wolfram [États-Unis]Insights from nanomedicine into chloroquine efficacy against COVID-19.
000748 (2020) Atte Sandelin [Finlande] ; Heidi H Rtel ; Leena Sepp Lassila [Finlande] ; Liisa Kaartinen [Finlande] ; Helena Rautala [Finlande] ; Timo Soveri [Finlande] ; Heli Simojoki [Finlande]Field trial to evaluate the effect of an intranasal respiratory vaccine protocol on bovine respiratory disease incidence and growth in a commercial calf rearing unit
000825 (2020) Hongzhou Lu [République populaire de Chine]Drug treatment options for the 2019-new coronavirus (2019-nCoV).
000834 (2020) Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine]Discovering drugs to treat coronavirus disease 2019 (COVID-19).
000844 (2020) Zhengtu Li [République populaire de Chine] ; Yongxiang Yi [République populaire de Chine] ; Xiaomei Luo [République populaire de Chine] ; Nian Xiong [République populaire de Chine] ; Yang Liu [République populaire de Chine] ; Shaoqiang Li [République populaire de Chine] ; Ruilin Sun [République populaire de Chine] ; Yanqun Wang [République populaire de Chine] ; Bicheng Hu [République populaire de Chine] ; Wei Chen [République populaire de Chine] ; Yongchen Zhang [République populaire de Chine] ; Jing Wang [République populaire de Chine] ; Baofu Huang [République populaire de Chine] ; Ye Lin [République populaire de Chine] ; Jiasheng Yang [République populaire de Chine] ; Wensheng Cai [République populaire de Chine] ; Xuefeng Wang [République populaire de Chine] ; Jing Cheng [République populaire de Chine] ; Zhiqiang Chen [République populaire de Chine] ; Kangjun Sun [République populaire de Chine] ; Weimin Pan [République populaire de Chine] ; Zhifei Zhan [République populaire de Chine] ; Liyan Chen [République populaire de Chine] ; Feng Ye [République populaire de Chine]Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis.
000857 (2020) Yaseen M. Arabi [Arabie saoudite] ; Robert Fowler [Canada] ; Frederick G. Hayden [États-Unis]Critical care management of adults with community-acquired severe respiratory viral infection
000979 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000B12 (2020) Peipei Song [Japon] ; Takashi Karako [Japon]COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern.
000B27 (2020) Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande]COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.
000B95 (2020) Jianjun Gao [République populaire de Chine] ; Zhenxue Tian [République populaire de Chine] ; Xu Yang [République populaire de Chine]Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
000C11 (2020) Chih-Cheng Lai [Taïwan] ; Yen Hung Liu [Taïwan] ; Cheng-Yi Wang [Taïwan] ; Ya-Hui Wang [Taïwan] ; Shun-Chung Hsueh [Taïwan] ; Muh-Yen Yen [Taïwan] ; Wen-Chien Ko [Taïwan] ; Po-Ren Hsueh [Taïwan]Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
000C54 (2020) Andrea Cortegiani [Italie] ; Giulia Ingoglia [Italie] ; Mariachiara Ippolito [Italie] ; Antonino Giarratano [Italie] ; Sharon Einav [Israël]A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.
000C55 (2020) Tian-Tian Yao [République populaire de Chine] ; Jian-Dan Qian [République populaire de Chine] ; Wen-Yan Zhu [République populaire de Chine] ; Yan Wang [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine]A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i -k "efficacy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i  \
                -Sk "efficacy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    efficacy
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021